Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US EPA allows sulfoxaflor use on sorghum in nine states

The US EPA has granted emergency exemptions to allow the use of Dow AgroSciences' insecticide, sulfoxaflor (trade-marked as Isoclast), for the control of sugar cane aphids (Melanaphis sacchari) on sorghum in nine states. The state authorities in Arkansas, Florida, Georgia, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas asserted that without the use of the insecticide uncontrolled aphid infestations would likely result in significant economic losses. They pointed to the presence of a new pest or a new biotype of M sacchari that could not be controlled with pesticides registered for use on the crop. The EPA has approved the request and established temporary tolerances that expire on December 31st 2017. It granted a similar exemption for Texas last year. Dow received US approval for the sulfoxaflor-based insecticides, Transform and Closer, for use on a wide range of crops in 2013.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG021760

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel